Outlook Therapeutics, Inc. Quarterly Current Ratio in % from Q4 2016 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Outlook Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q4 2016 to Q2 2024.
  • Outlook Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 81.7 %, a 43.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 81.7 -62.7 -43.4% Jun 30, 2024
Q1 2024 77.4 -108 -58.4% Mar 31, 2024
Q4 2023 79.2 -149 -65.3% Dec 31, 2023
Q3 2023 122 -112 -48% Sep 30, 2023
Q2 2023 144 -121 -45.6% Jun 30, 2023
Q1 2023 186 -68.2 -26.8% Mar 31, 2023
Q4 2022 228 -20.4 -8.2% Dec 31, 2022
Q3 2022 234 +60.1 +34.7% Sep 30, 2022
Q2 2022 265 +119 +81.3% Jun 30, 2022
Q1 2022 254 +110 +76.9% Mar 31, 2022
Q4 2021 249 +154 +162% Dec 31, 2021
Q3 2021 173 +93.8 +118% Sep 30, 2021
Q2 2021 146 +76.3 +109% Jun 30, 2021
Q1 2021 144 +88.2 +159% Mar 31, 2021
Q4 2020 95.1 +49.8 +110% Dec 31, 2020
Q3 2020 79.6 +42.1 +112% Sep 30, 2020
Q2 2020 70 +45.8 +189% Jun 30, 2020
Q1 2020 55.4 +37.8 +215% Mar 31, 2020
Q4 2019 45.2 +24.5 +118% Dec 31, 2019
Q3 2019 37.5 +7.07 +23.2% Sep 30, 2019
Q2 2019 24.2 -7.53 -23.7% Jun 30, 2019
Q1 2019 17.6 -3.33 -15.9% Mar 31, 2019
Q4 2018 20.8 +4.87 +30.6% Dec 31, 2018
Q3 2018 30.4 +23.7 +350% Sep 30, 2018
Q2 2018 31.7 +23.1 +268% Jun 30, 2018
Q1 2018 20.9 -1.39 -6.24% Mar 31, 2018
Q4 2017 15.9 -9.06 -36.3% Dec 31, 2017
Q3 2017 6.76 Sep 30, 2017
Q2 2017 8.61 Jun 30, 2017
Q1 2017 22.3 Mar 31, 2017
Q4 2016 25 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.